Our results further support this finding, demonstrating that chronic treatment with a CXCR4 antagonist increased blood neutrophil counts and corrected peripheral blood neutropenia in CXCR2 LOF mice. The gene discussed is CXCR2; the disease is Decreased total neutrophil count.